Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
REVENUES $ 115,000 $ 106,000 $ 396,000 $ 482,000
OPERATING EXPENSES        
Research and development 3,584,000 2,336,000 10,185,000 6,956,000
General and administrative 3,002,000 1,978,000 8,500,000 6,939,000
TOTAL OPERATING EXPENSES 6,586,000 4,314,000 18,685,000 13,895,000
NET OPERATING LOSS (6,471,000) (4,208,000) (18,289,000) (13,413,000)
OTHER INCOME, NET        
Interest and investment income 177,000 14,000 323,000 39,000
Other income (expense) 8,000 (6,000) 4,000 (7,000)
TOTAL OTHER INCOME, NET 185,000 8,000 327,000 32,000
LOSS BEFORE INCOME TAXES (6,286,000) (4,200,000) (17,962,000) (13,381,000)
Benefit from income taxes (11,000) (16,000) (19,000) (40,000)
NET LOSS (6,275,000) (4,184,000) (17,943,000) (13,341,000)
Foreign currency translation adjustment, net of tax 10,000 (17,000) (5,000) 46,000
COMPREHENSIVE LOSS $ (6,265,000) $ (4,201,000) $ (17,948,000) $ (13,295,000)
NET LOSS PER SHARE - BASIC AND DILUTED (in dollars per share) $ (0.23) $ (0.28) $ (0.73) $ (0.94)
Weighted average shares outstanding-basic and diluted (in shares) 27,006,046 14,757,688 24,645,658 14,233,774